{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:53:05Z","timestamp":1793890385496,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mermaid Foundation"},{"DOI":"10.13039\/501100005940","name":"Danish Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Herlev Hospital Research Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Among women, ovarian cancer (OC) is one of the most severe forms of malignancy, accounting for a low 5-year survival rate, of approximately 52%. Early symptoms are unspecific and hence hard to detect. The origin of OC and its subtypes are still unclear, underlying the need for efficient diagnostic biomarkers. In that regard, epigenetics studies are emerging in cancer diagnostics, with encouraging outcomes. Among them, DNA methylation profiling has shown that the origins of the cancer epigenome are associated with molecular factors that are crucial to carcinogenesis, such as regulation of oncogenes and tumor suppressors. Furthermore, those events have been detected in abnormal cell morphology before neoplastic formation, indicating its potential crucial use in the OC diagnostics in the future. Nonetheless, studies are limited, and whether methylation analysis can be performed optimally in formalin-fixed paraffin-embedded (FFPE) preparations of OC cases is still elusive. In the present report, we investigated the performance of DNA methylation analysis in FFPE samples, compared to their matched fresh frozen tissue in a small cohort of OC samples. We found that the overall DNA methylation profile in FFPE tissue showed high concordance to that found in fresh frozen tissue, and accounting for the small cohort size, the differentially methylated sites found primarily in frozen tissue, compared to benign samples, were also reproducible in FFPE. Overall, by using samples from our current clinical setting of tissue preservation, these preliminary observations might provide insights into the clinical use of FFPE tissues in methylation studies without critically compromising the outcome.<\/jats:p>","DOI":"10.1007\/s43032-021-00589-0","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T22:34:00Z","timestamp":1619303640000},"page":"3212-3218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["DNA Methylation in Ovarian Tumors\u2014a Comparison Between Fresh Tissue and FFPE Samples"],"prefix":"10.1007","volume":"28","author":[{"given":"Douglas V.N.P.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hentze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm J.","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4689-5658","authenticated-orcid":false,"given":"Estrid V.","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"589_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/CLEP.S99479","volume":"8","author":"SM Sorensen","year":"2016","unstructured":"Sorensen SM, et al. Danish Gynecological Cancer Database. Clin Epidemiol. 2016;8:485\u201390.","journal-title":"Clin Epidemiol"},{"key":"589_CR2","doi-asserted-by":"publisher","first-page":"e0225249","DOI":"10.1371\/journal.pone.0225249","volume":"14","author":"DNP Oliveira","year":"2019","unstructured":"Oliveira DNP, Carlsen AL, Heegaard NHH, Prahm KP, Christensen IJ, H\u00f8gdall CK, et al. Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass. PLoS One. 2019;14:e0225249.","journal-title":"PLoS One"},{"key":"589_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nature21373","volume":"543","author":"F Neri","year":"2017","unstructured":"Neri F, Rapelli S, Krepelova A, Incarnato D, Parlato C, Basile G, et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature. 2017;543:72\u20137.","journal-title":"Nature"},{"key":"589_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A Bird","year":"2002","unstructured":"Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6\u201321.","journal-title":"Genes Dev"},{"key":"589_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gde.2017.06.007","volume":"46","author":"O Bogdanovic","year":"2017","unstructured":"Bogdanovic O, Lister R. DNA methylation and the preservation of cell identity. Curr Opin Genet Dev. 2017;46:9\u201314.","journal-title":"Curr Opin Genet Dev"},{"key":"589_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11:726\u201334.","journal-title":"Nat Rev Cancer"},{"key":"589_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683\u201392.","journal-title":"Cell"},{"key":"589_CR8","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002;21:5400\u201313.","journal-title":"Oncogene"},{"key":"589_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/epi.09.47","volume":"2","author":"A Jones","year":"2010","unstructured":"Jones A, Lechner M, Fourkala EO, Kristeleit R, Widschwendter M. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers. Epigenomics. 2010;2:9\u201338.","journal-title":"Epigenomics"},{"key":"589_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008274","volume":"4","author":"AE Teschendorff","year":"2009","unstructured":"Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One. 2009;4:e8274.","journal-title":"PLoS One"},{"key":"589_CR11","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1158\/0008-5472.CAN-04-1529","volume":"64","author":"I Ibanez de Caceres","year":"2004","unstructured":"Ibanez de Caceres I, et al. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res. 2004;64:6476\u201381.","journal-title":"Cancer Res"},{"key":"589_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/ijc.23563","volume":"123","author":"H Fiegl","year":"2008","unstructured":"Fiegl H, Windbichler G, Mueller-Holzner E, Goebel G, Lechner M, Jacobs IJ, et al. HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer. International Journal of Cancer Journal International du Cancer. 2008;123:725\u20139.","journal-title":"International Journal of Cancer Journal International du Cancer"},{"key":"589_CR13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.annonc.2020.04.013","volume":"31","author":"WC Taylor","year":"2020","unstructured":"Taylor WC. Comment on 'Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA' by M. C Liu et al Ann Oncol. 2020;31:1266\u20137.","journal-title":"C Liu et al Ann Oncol"},{"key":"589_CR14","first-page":"67","volume":"59","author":"M Esteller","year":"1999","unstructured":"Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999;59:67\u201370.","journal-title":"Cancer Res"},{"key":"589_CR15","first-page":"892","volume":"60","author":"M Sanchez-Cespedes","year":"2000","unstructured":"Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000;60:892\u20135.","journal-title":"Cancer Res"},{"key":"589_CR16","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1096\/fj.09-150490","volume":"24","author":"RP Talens","year":"2010","unstructured":"Talens RP, Boomsma DI, Tobi EW, Kremer D, Jukema JW, Willemsen G, et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 2010;24:3135\u201344.","journal-title":"FASEB J"},{"key":"589_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/bioinformatics\/bts170","volume":"28","author":"AE Teschendorff","year":"2012","unstructured":"Teschendorff AE, Widschwendter M. Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics. 2012;28:1487\u201394.","journal-title":"Bioinformatics"},{"key":"589_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/gm323","volume":"4","author":"AE Teschendorff","year":"2012","unstructured":"Teschendorff AE, Jones A, Fiegl H, Sargent A, Zhuang JJ, Kitchener HC, et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med. 2012;4:24.","journal-title":"Genome Med"},{"key":"589_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2217\/pme.15.53","volume":"13","author":"N Pashayan","year":"2016","unstructured":"Pashayan N, Reisel D, Widschwendter M. Integration of genetic and epigenetic markers for risk stratification: opportunities and challenges. Personalized medicine. 2016;13:93\u20135.","journal-title":"Personalized medicine"},{"key":"589_CR20","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1038\/s41598-018-24781-6","volume":"8","author":"I Wimmer","year":"2018","unstructured":"Wimmer I, Tr\u00f6scher AR, Brunner F, Rubino SJ, Bien CG, Weiner HL, et al. Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples. Sci Rep. 2018;8:6351.","journal-title":"Sci Rep"},{"key":"589_CR21","unstructured":"R. C. Team (2017) R: A language and environment for statistical computing."},{"key":"589_CR22","unstructured":"K. D. Hansen, M. Aryee, W. Timp (2020) minfiData: example data for the Illumina methylation 450k array."},{"key":"589_CR23","doi-asserted-by":"crossref","unstructured":"B. Phipson, J. Maksimovic, A. Oshlack, missMethyl: an R package for analyzing data from Illumina's HumanMethylation450 platform. Bioinformatics 32, 286-288 (2016).","DOI":"10.1093\/bioinformatics\/btv560"},{"key":"589_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-8935-8-6","volume":"8","author":"TJ Peters","year":"2015","unstructured":"Peters TJ, Buckley MJ, Statham AL, Pidsley R, Samaras K, V Lord R, et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 2015;8:6.","journal-title":"Epigenetics Chromatin"},{"key":"589_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13059-014-0503-2","volume":"15","author":"JP Fortin","year":"2014","unstructured":"Fortin JP, Labbe A, Lemire M, Zanke BW, Hudson TJ, Fertig EJ, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 2014;15:503.","journal-title":"Genome Biol"},{"key":"589_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8:203\u20139.","journal-title":"Epigenetics"},{"key":"589_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, et al. Comparison of beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.","journal-title":"BMC Bioinformatics"},{"key":"589_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13148-017-0333-7","volume":"9","author":"T Kling","year":"2017","unstructured":"Kling T, Wenger A, Beck S, Caren H. Validation of the MethylationEPIC BeadChip for fresh-frozen and formalin-fixed paraffin-embedded tumours. Clin Epigenetics. 2017;9:33.","journal-title":"Clin Epigenetics"},{"key":"589_CR29","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.18632\/oncotarget.14739","volume":"8","author":"AC Espinal","year":"2017","unstructured":"Espinal AC, Wang D, Yan L, Liu S, Tang L, Hu Q, et al. A methodological study of genome-wide DNA methylation analyses using matched archival formalin-fixed paraffin embedded and fresh frozen breast tumors. Oncotarget. 2017;8:14821\u20139.","journal-title":"Oncotarget"},{"key":"589_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/epi.15.114","volume":"8","author":"S Moran","year":"2016","unstructured":"Moran S, Arribas C, Esteller M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 2016;8:389\u201399.","journal-title":"Epigenomics"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-021-00589-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-021-00589-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-021-00589-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T23:56:47Z","timestamp":1634687807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-021-00589-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1007\/s43032-021-00589-0","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"14 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out according to the guidelines of the Declaration of Helsinki, including written informed consent from all subjects, and it has been approved by the Danish National Committee for Research Ethics, Capital Region (approval codes KF01-227\/03 and KF01-143\/04). All patients were followed until either death of any cause, emigration, or January 17<sup>th<\/sup>, 2015.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}